Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Chronic cough and phlegm in young adults

I. Cerveri, S. Accordini, A. Corsico, M.C. Zoia, L. Carrozzi, L. Cazzoletti, M. Beccaria, A. Marinoni, G. Viegi, R. de Marco for the ISAYA Study Group
European Respiratory Journal 2003 22: 413-417; DOI: 10.1183/09031936.03.00121103
I. Cerveri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Accordini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Corsico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.C. Zoia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Carrozzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Cazzoletti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Beccaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Marinoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Viegi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. de Marco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines underline that the presence of chronic cough and sputum production before airflow obstruction offers a unique opportunity to identify subjects at risk of chronic obstructive pulmonary disease for an early intervention. Current epidemiological data on these subjects are scant.

Between 1998–2000, the authors evaluated the prevalence and characteristics of these symptoms by a multicentre cross-sectional survey of Italian people aged between 20–44 yrs from the general population (Italian Study on Asthma in Young Adults (ISAYA)). Besides the questions on asthma, more than 18,000 subjects answered the question: “Have you had cough and phlegm on most days for as much as 3 months per year and for at least two successive years?”

The adjusted prevalence of subjects with chronic cough and phlegm was 11.9%, being 11.8% in males and 12.0% in females. From these subjects ∼20% reported coexisting asthma and ∼30%, predominately females, were nonsmokers. The survey showed thatsex (female), smoking and low socioeconomic status were significantly and independently associated with chronic cough and phlegm, current smoking playing the major role.

The prevalence of subjects with chronic cough and phlegm is startlingly high among young adults. Further follow-up studies are needed to establish how many of them will go on to develop chronic obstructive pulmonary disease.

  • chronic obstructive pulmonary disease
  • cross-sectional studies
  • health surveys
  • risk factors
  • smoking

This work was partially supported by grants from: Italian Ministry of University Scientific and Technological Research (MURST); GlaxoSmithKline Italia; National Health Service, AUSL Ferrara; National Health Service, AUSL Pavia; National Health Service, ASL 4 Turin; IRCCS Policlinico S. Matteo; Municipality of Udine; Councillorship for Health, Modena Province; Pavia Province; Siracusa Province; Veneto Region.

The enormous cost of chronic obstructive pulmonary disease (COPD) and its increase over the foreseeable future are constant reminders that the disease is not adequately managed 1, 2. In previous years strong epidemiological evidence has shown chronic cough and phlegm production are significantly related to COPD death 3–5, excess FEV1 decline 6, 7, and increased risk of subsequent hospitalisation because of COPD 6. This information overturned the beliefs, based on classical epidemiological studies conducted in the 1960s, that mucus hypersecretion and airflow obstruction are largely independent disease processes 8, 9. The recently published guidelines of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) underline that the presence of chronic cough and sputum production before airflow obstruction offers a unique opportunity to identify subjects at risk for COPD (GOLD stage 0) for an early intervention 10. In a recent study Vestbo and Lange 11 tried to validate this staging approach, retrospectively, using data from three surveys in the Copenhagen City Heart Study. This study examined a sample taken from the general population, at baseline and after 5 and 15 yrs, by taking spirometric readings at each stage. The authors concluded that GOLD stage 0 is of little help in identifying subjects at risk for COPD. This statement is a key point that requires further investigation as it could profoundly influence future strategies for the early detection and prevention of COPD 12.

Current epidemiological data on subjects with chronic cough and phlegm are scant. Rapid changes in environmental, behavioural (particularly smoking habits) and socioeconomic conditions in the last few decades throughout the world 13, mean that ad hoc population-based studies are needed 14. The Italian Study on Asthma in Young Adults (ISAYA) provided the present authors the opportunity to assess the prevalence of subjects with chronic cough and phlegm in the youngest age classes and to evaluate these subjects' main characteristics and risk factors.

Methods

Study design and subjects

The ISAYA was a multicentre, cross-sectional survey of the young adult population, specifically aimed at assessing the variations of asthma and the current management of asthmatics in Italy 15–17. The survey was carried out between 1998 and 2000 in nine Italian centres, of these six were in northern Italy (Udine, Pavia, Turin, Verona, Sassuolo, and Ferrara), and three were in central/southern Italy (Pisa, Sassari and Siracusa).

The design of the study was the same as that used in stage I of the European Community Respiratory Health Survey (ECRHS) 18. Each centre selected an up-to-date sampling frame of the residents of the target area, from which a random sample of about 3,000 people aged between 20–44 yrs (male:female, 1:1) was chosen. A screening questionnaire was sent by post to each subject up to three times in the case of no response; finally the questionnaire was administered by phone to the remaining nonresponders. The questionnaire used has been published elsewhere and tested in a pilot study in 1998 19, it contains validated questions, mostly taken from the ECRHS questionnaire.

There were 25,969 eligible subjects. The overall response rate to the screening questionnaire was 72.7% (18,873 subjects). From the respondents, 18,645 subjects answered the question on chronic cough and phlegm.

Data management and statistical analysis

Cases were identified on the basis of a positive response to the question: “Have you had cough and phlegm on most days for as much as three months per year and for at least two successive years?” A subgroup of subjects with coexisting asthma was identified according to the positive answer to any of the questions: “Have you had an attack of asthma at any time in the last twelve months?”, “Are you currently taking any medicines (including inhalers, aerosols or tablets) for asthma?”, “Have you ever had asthma?”

Subjects were classified according to smoking habits as current smokers (0–14 pack-yrs “light smokers”, ≥15 pack-yrs “moderate-heavy smokers”), past smokers, or nonsmokers. Socioeconomic status was classified into four classes according to the type of occupation; these were as follows: managers, entrepreneurs, businessmen, clerks; retired people, students and housewives; unemployed and finally blue-collar workers.

As the centres had different final cumulative response rates, obtained with different percentages of telephone interviews, for the sake of comparison the prevalence rates were adjusted for cumulative response rate and type of contact (telephone versus postal), and for age and sex also. For this purpose, each subject was attributed the median of the cumulative response rate of the contact to which he/she had answered (first, second, third postal contact and telephone interview) and a dummy indicator of the type of interview (telephone versus postal). Adjusted prevalence rates were then obtained through a logistic regression model, considering the variable of interest as the dependent variable and sex, age (categorised in 5‐yr classes), cumulative response rate and type of interview as the covariates. The prevalence in each centre was estimated setting the distribution of age, sex and type of contact equal to the average distribution, and the cumulative response rate to the overall mean. Prevalence rates with their 95% confidence intervals (CIs) were obtained.

Chi-squared tests, two-sample unpaired t‐tests and median tests were used when needed. A multilevel binary response model 20, with subjects nested within centres, was used to assess the independent effect of sex, smoking habits and socioeconomic status on the prevalence of chronic cough and phlegm according to the presence of coexisting asthma, considering the absence of chronic cough and phlegm as the reference category. Odds ratios (ORs) were also adjusted for season of response, cumulative response rate and type of interview. The model had a random intercept term at the level of the centre and all predictor variables as fixed effects.

Results

The overall prevalence of subjects with chronic cough and phlegm was 11.9% (95% CI: 11.4–12.4), of which the prevalence of subjects with chronic cough and phlegm without coexisting asthma was 9.5% (9.1–10) and the prevalence of those with coexisting asthma was 2.2% (2.0–2.4). The prevalence was not significantly different between males and females either in the whole group of subjects with chronic cough and phlegm or in those with and without coexisting asthma (table 1⇓).

View this table:
  • View inline
  • View popup
Table 1

Prevalence of subjects with chronic cough and phlegm and of those with and without coexisting asthma according to sex

The prevalence of current smokers was 33.3% (32.5–34.0) and varied significantly according to sex: 37.1% (36.1–38.1) in males and 29.9% (29–30.8) in females (p<0.001). The prevalence of past smokers was 13.1% (12.6–13.6), 13.9% (13.2–14.6) in males and 12.4% (11.7–13.1) in females (p=0.001). The median (95% CI) number of pack-yrs was significantly higher among males than among females 10.2 (9.7–10.6) versus 7.5 (7.0–7.8) pack-yrs (p<0.001) and, on average, males started smoking significantly earlier than females (p<0.001). According to the authors classification, the percentage of moderate-heavy smokers was higher in males than in females (33.1% versus 22.9%; p<0.001).

Subjects with chronic cough and phlegm included a larger proportion of current smokers (53.5% versus 30.7%, p<0.001), in particular moderate-heavy smokers (22.4% versus 7.7%), than those without chronic cough and phlegm. The prevalence of subjects with chronic cough and phlegm progressively increased from among nonsmokers to among moderate-heavy smokers (fig. 1⇓) and from among people of the higher socioeconomic classes to among the unemployed and workers (fig. 2⇓). About 30% of subjects with chronic cough and phlegm were nonsmokers. In comparison with current smokers, they were significantly younger, there were significantly more females, and more subjects with coexisting asthma and nasal allergies. The socioeconomic status of this subgroup was also different, as it contained more housewives and fewer workers (table 2⇓).

Fig. 1.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.—

Prevalence (95% confidence interval) of chronic cough and phlegm plotted by sex (□: males; ┘: females) and smoking habits. The prevalence is adjusted for age, cumulative response rate and type of contact (telephone versus mail).

Fig. 2.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.—

Prevalence (95% confidence interval) of chronic cough and phlegm plotted by sex (□: males; ┘: females) and socioeconomic status. Adjusted for age, cumulative response rate and type of contact (telephone versus mail).

View this table:
  • View inline
  • View popup
Table 2

Characteristics of subjects with chronic cough and phlegm according to smoking habits

From the total of 2,318 subjects with chronic cough and phlegm, 455 (19.8%) (204 males and 251 females) reported coexisting asthma. These subjects were significantly younger than subjects reporting only chronic cough and phlegm (31.9 versus 33.4 yrs, p<0.001), and more often reported wheezing (71.0% versus 29.4%, p<0.001) and nasal allergies (64.1% versus 31.1%, p<0.001). Moreover, these subjects were characterised by a significantly lower percentage of current smokers (40.5% versus 56.7%, p<0.001) and a lower cumulative consumption of cigarettes (8.4 versus 13.4 pack-yrs) than subjects reporting only chronic cough and phlegm. Anyway, the percentage of current smokers in subjects with chronic cough and phlegm with coexisting asthma was higher than that of the population as a whole.

Table 3⇓ shows the adjusted ORs for the association between the presence of chronic cough and phlegm and sex, smoking habit and socioeconomic status for subjects with chronic cough and phlegm divided according to whether or not they also had asthma. All the three factors were significantly and independently associated with chronic cough and phlegm in both groups. The effect of smoking habits was much less evident in those with coexisting asthma, and not apparently related to the number of cigarettes smoked.

View this table:
  • View inline
  • View popup
Table 3

The association between chronic cough and phlegm and sex, smoking habits and socioeconomic status according to the presence of asthma

Discussion

The prevalence of subjects with chronic cough and phlegm is startlingly high among young adults without difference between sex. Alongside smoking, which is already well known for playing a major role, sex and low socioeconomic status were significantly and independently associated with chronic cough and phlegm. Even considering chronic respiratory symptoms in many of these subjects may be reversible or attributable to diseases not resulting in COPD, this data suggests how large the bottom of the COPD iceberg is.

Estimates in past decades showed chronic cough and phlegm were more prevalent among males than females, a finding attributed to higher smoking rates and more frequent occupational exposure for males 21, 22. According to other studies 13, 23, 24, particularly those with data collected more recently, the authors found that the prevalence of chronic cough and phlegm among females has already reached that among males and that to be female has an effect on chronic cough and phlegm independently from smoking. Even if studies of a sex-related effect of smoking on respiratory outcomes have not been conclusive, there is increasing evidence of a higher prevalence of smoking and long-term cumulative effect of smoking among women after the 1970s. Some studies had suggested a possibly greater susceptibility to the adverse pulmonary effects of smoking 13, 25. However, it is difficult to control for all the circumstances of exposure and the effects of smoking in females could be underestimated, since males not only smoke more than females, but they have often started earlier as observed in the present study and have a higher rate of inhalation than females 26.

Although smoking was the major risk factor, the authors observed that a considerable proportion of symptomatic subjects were nonsmokers. These subjects were predominantly females, and frequently reported coexisting asthma and nasal allergies. Epidemiological studies have already shown that 5–12% of patients with a diagnosis of COPD have never smoked and there is evidence of an increasing incidence with increasing age 27; these subjects were predominantly females and there was an association with lower income 28. Therefore it should be considered that, at least in some of the subjects with chronic cough and phlegm, particularly the nonsmokers, a different pathogenesis such as asthma, chronic rhinosinusitis or gastroesophageal reflux could be involved. These patients could have a different disease evolution and may not go on to develop bronchial obstruction in the future, particularly if properly diagnosed and treated.

In the present study sample, 20% of subjects with chronic cough and phlegm also reported asthma. It is well recognised that there is an overlap between asthma and COPD in some patients but it cannot be excluded that chronic cough and phlegm are purely expressions of asthma. The earlier onset of symptoms in these patients, the association with nasal allergies, as a marker of atopy, wheezing and the minor role of current smoking in these subjects seem to suggest that many of them have only asthma.

Even if only some of the subjects with chronic cough and phlegm will go on to develop chronic airflow obstruction, all subjects with chronic cough and phlegm should be carefully evaluated, presumably mainly in the primary care context but in any setting that they are first recognised. The GOLD guidelines stated that spirometry should be undertaken for any patients who have chronic cough and sputum production even if they do not have dyspnoea. All the moderate-heavy smokers should also undergo spirometry because they could be more motivated to stop smoking if they realise that their respiratory problems are caused by smoking and that they are at risk of developing COPD 29. Smoking cessation has been proven to be capable of reversing the steep decline in lung function 30 and, at present, it is the only intervention able to do so. Recent results of the Lung Health Study showed that males and females who quit smoking at the beginning of the study and were still abstaining after 11 yrs had almost halved the decline of FEV1 per year as compared to those who continued to smoke throughout the 11 yrs. At 11 yrs, 38% of individuals who continued to smoke had a FEV1 <60% of the predicted normal value, as compared with 10% in the individuals who stopped smoking permanently. Anthonisen et al 31 concluded that the loss of lung function among continuing smokers is more rapid than previously suspected. It is particularly important to study young adults, as the present authors did, because there is evidence suggesting that the benefits of smoking cessation are greatest at younger ages, usually before 45 yrs 32.

In a recent study Vestbo and Lange 11 raised an important point, showing that chronic cough and phlegm are not stable features since, in their retrospective study, ∼40% of subjects who reported chronic respiratory symptoms no longer did so after 5 yrs. Smoking cessation was found to predict the subsequent absence of chronic symptoms. The present authors' interpretation on finding that disappearance of chronic mucus hypersecretion is associated with young age and smoking cessation differs from that of Vestbo and Lange 11 as it indicates the opportunity for early detection of these subjects in order to promote smoking cessation 12.

The strengths of this present epidemiological study are its large sample size, robust study design and statistical analysis. In particular, differently from other studies, the present study sample was selected from young adults, allowing the authors to estimate how large the bottom of the COPD iceberg is; in fact, during the course of such a chronic disease, patients are supposed to move from low stages upwards.

The limitations of this present study are the use of a simple screening questionnaire that does not allow deep investigation on the specific characteristics of the subjects and the absence of spirometry. In the authors' previous international study, which focused on subjects of the same age range, the prevalence of airflow obstruction in young adults with chronic cough and phlegm was only 8.4% 33.

In conclusion, the impressively high prevalence of subjects with chronic cough and phlegm among young adults, although only some of them will develop chronic obstructive pulmonary disease, supports the projections of a remarkable increase of chronic obstructive pulmonary disease over the foreseeable future. The final message is that subjects with chronic cough and phlegm should be carefully evaluated in the primary care context or in any other setting as soon as these symptoms are first recognised and should have access to spirometry. Unfortunately, the present cross-sectional study does not answer the inevitable question surrounding the progression from cough and sputum to airflow obstruction or indeed whether intervention can prevent the inevitable. Prospective population-based studies are needed, particularly in the youngest age ranges, to validate the predictive value of chronic cough and phlegm in the development of chronic obstructive pulmonary disease.

Acknowledgments

The authors are very grateful to R. Stenner for her assistance in the preparation of the manuscript.

The Italian Study on Asthma in Young Adults (ISAYA) Study Group: Project leader: R. de Marco; Coordinating centre: R. de Marco, S. Accordini, G. Verlato, E. Zanolin; Steering Committee: M. Bugiani, O. Buriani, L. Carrozzi, R. Dallari, R. de Marco, G. Giammanco, F. Ginesu, A. Marinoni, A. Poli, P. Struzzo; Principal researchers: O. Buriani, R. Cavallini, C. Saletti, M. Cellini, M. Faustini, A. de Togni (Ferrara); A. Marinoni, A. Carolei, C. Montomoli, S. Villani, M. Comelli, M.Ponzio, M. Grassi, C. Rezzani, L. Casali, I. Cerveri, M.C. Zoia, A. Corsico, S. Colato, G. Moscato, L. Perfetti (Pavia); L. Carrozzi, G. Viegi, F. Pistelli, F. Di Pede, P.L. Paggiaro, A. Santolicandro, P. Giovannetti (Pisa, Lucca and Livorno); F. Ginesu, P. Pirina, S. Ostera, G.P. Pinna, A. Farre, S. Imparato (Sassari); R. Dallari, E. Turrini, M. Foglia (Sassuolo); G. Giammanco, S. Pignato, A. Rotondo, A. Cuspilici (Siracusa); M. Bugiani, P. Piccioni, A. Carosso, W. Arossa, E. Caria, G. Castiglioni, E. Migliore, C. Romano, D. Fabbro, G. Ciccone, C. Magnani, P. Dalmasso, R. Bono, G. Gigli, A. Giraudo, M.C. Brussino, C. Bucca, G. Rolla (Turin); P. Struzzo, U. Orefice, M. Schneider, F. Chittaro, D. Peresson (Udine); R. de Marco, G. Verlato, S. Accordini, M.E. Zanolin, F. Locatelli, L. Cazzoletti, L. Battisti, C. Pattaro, A. Poli, N. Dorigo, S. Cantarelli, D. Ciresola, V. Lo Cascio, M. Olivieri, M. Ferrari, C. Biasin (Verona); P. Lauriola, G. Danielli, D. Sesti, E. Ghigli (ARPA Emilia-Romagna); P. Natale, M. Grosa (ARPA Piemonte); A. Tacconi, P. Frontero, A. Salomoni (ARPA Veneto).

  • Received December 27, 2002.
  • Accepted May 15, 2003.
  • © ERS Journals Ltd

References

  1. ↵
    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause, 1990–2020. Global Burden of Disease Study. Lancet 1997;349:1498–1504.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Gross NJ. The GOLD standard for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1047–1048.
    OpenUrlPubMedWeb of Science
  3. ↵
    Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? A 22‐year mortality survey of 1,061 working men. Am Rev Respir Dis 1986;134:688–693.
    OpenUrlPubMedWeb of Science
  4. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989;140:s49–s55.
  5. ↵
    Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45:579–585.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Vestbo J, Prescott E, Lange P, and the Copenhagen City Heart Study Group. Association of chronic mucus secretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med 1996;153:1530–1535.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992;140:855–859.
    OpenUrl
  8. ↵
    Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645–1648.
  9. ↵
    Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983;128:491–500.
    OpenUrlPubMedWeb of Science
  10. ↵
    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256–1276.
    OpenUrlCrossRefPubMed
  11. ↵
    Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 2002;166:329–332.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Cerveri I, Corsico A, Zoia MC. GOLD stage 0. Am J Respir Crit Care Med 2003;167:936.
  13. ↵
    Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000;53:755–761.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Cerveri I, Corsico A, Zoia MC. COPD screening in high-risk groups. Chest 2003;123:959.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    de Marco R, Poli A, Ferrari M, Accordini S, et al. The impact of climate and traffic-related NO2 on the prevalence of asthma and allergic rhinitis in Italy. Clin Exp Allergy 2002;32:1405–1412.
    OpenUrlCrossRefPubMedWeb of Science
  16. de Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A, Giammanco G. Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy. J Allergy Clin Immunol 2002;110:228–235.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    de Marco R, Bugiani M, Cazzoletti L, et al. The control of asthma in Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy 2003;58:221–228.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Burney PGC, Luczynska C, Chinn S, Jarvis D, for the European Community Respiratory Health Survey (ECRHS). The European Community Respiratory Health Survey. Eur Respir J 1994;7:954–960.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    de Marco R, Zanolin ME, Accordini S, et al. A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J 1999;14:1044–1048.
    OpenUrlAbstract
  20. ↵
    Goldstein H.. Multilevel statistical modelsLondon, Edward Arnold, 1995.
  21. ↵
    Sobradillo Peña V, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC Multicentre Epidemiological Study. Chest 2000;118:981–989.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Viegi G, Pedreschi M, Baldacci S, et al. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int J Tuberc Lung Dis 1999;3:1034–1042.
    OpenUrlPubMedWeb of Science
  23. ↵
    Antò JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001;17:982–994.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms, and diseases: a comparative study between Northern Sweden and Northern Finland: report from the FinEsS Study. Chest 2001;119:852–861.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Prescott EIB, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal study. Eur Respir J 1997;10:822–827.
    OpenUrlAbstract
  26. ↵
    Prescott E, Osler M, Vestbo J. Importance of detailed adjustment for smoking when comparing morbidity and mortality in men and women in a Danish population study. Eur J Publ Health 1998;8:166–169.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001;164:372–377.
    OpenUrlPubMedWeb of Science
  28. ↵
    Birring SS, Brightling CE, Bradding P, et al. Clinical, radiological and induced sputum features of COPD in non-smokers. A descriptive study. Am J Respir Crit Care Med 2002;166:1078–1083.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding. BMJ 2002;324:1370–1374.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Anthonissen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of FEV1: the lung health study. JAMA 1994;272:1497–1505.
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675–679.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    Sherrill DL, Holberg CJ, Enrigh PL, et al. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994;149:591–597.
    OpenUrlPubMedWeb of Science
  33. ↵
    Cerveri I, Accordini S, Verlato G, et al. for the European Community Respiratory Health Survey (ECRHS) Study Group. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001;18:85–92.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 22 Issue 3 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Chronic cough and phlegm in young adults
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Chronic cough and phlegm in young adults
I. Cerveri, S. Accordini, A. Corsico, M.C. Zoia, L. Carrozzi, L. Cazzoletti, M. Beccaria, A. Marinoni, G. Viegi, R. de Marco
European Respiratory Journal Sep 2003, 22 (3) 413-417; DOI: 10.1183/09031936.03.00121103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Chronic cough and phlegm in young adults
I. Cerveri, S. Accordini, A. Corsico, M.C. Zoia, L. Carrozzi, L. Cazzoletti, M. Beccaria, A. Marinoni, G. Viegi, R. de Marco
European Respiratory Journal Sep 2003, 22 (3) 413-417; DOI: 10.1183/09031936.03.00121103
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Oesophageal pH monitoring is of limited value in the diagnosis of “reflux-cough”
  • Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
  • Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough
Show more Clinical Forum

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society